GSK PLC-SPON ADR (GSK)       35.3  -0.04 (-0.11%)

Company Profile

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. The company is headquartered in Brentford, Middlesex and currently employs 90,096 full-time employees. The firm makes vaccines and specialty medicines to prevent and treat disease. Its segments include Commercial Operations and Research and Development. The company develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. The company has developed a new monoclonal antibody treatment for COVID-19. Its product areas include vaccines, specialty medicines, and general medicines. Its vaccine portfolio includes more than 20 vaccines that help protect people from a range of diseases and infections throughout their lives. Its specialty medicines include medicines for immune-mediated conditions, including the chronic autoimmune condition lupus, respiratory disease, and human immunodeficiency virus (HIV). Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD), antibiotics and medicines for skin diseases. The company has a global network of about 12 vaccines manufacturing sites.

Company Info

GSK PLC-SPON ADR

980 Great West Road

Brentford MIDDLESEX TW8 9GS

P: 442080475000.0

CEO: Emma Walmsley

Employees: 90096

Website: https://www.gsk.com/